Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

July 01, 2006; Volume 33,Issue 7
  • You have access
    Improving outcomes in rheumatoid arthritis: what determines decisions to change ineffective therapy?
    Tuulikki Sokka and Heidi Mäkinen
    The Journal of Rheumatology July 1 2006, 33 (7) 1213-1215;
  • You have access
    The predictive power of anti-cyclic citrullinated peptide antibodies: window into understanding gene/ environment/immunity interactions.
    Wonuk Lee and Michael H Weisman
    The Journal of Rheumatology July 1 2006, 33 (7) 1216-1218;
  • You have access
    Further evidence for insufficient hypothalamic-pituitary-glandular axes in polymyalgia rheumatica.
    Rainer H Straub and Maurizio Cutolo
    The Journal of Rheumatology July 1 2006, 33 (7) 1219-1223;
  • You have access
    Outcome in small-vessel systemic vasculitis.
    Raashid A Luqmani and Oliver Flossmann
    The Journal of Rheumatology July 1 2006, 33 (7) 1224-1227;
  • You have access
    Towards international guidelines for the management of psoriatic arthritis.
    Dafna D Gladman and Philip J Mease
    The Journal of Rheumatology July 1 2006, 33 (7) 1228-1230;
  • You have access
    Cyclooxygenase-2 genotype and rheumatoid arthritis.
    Kyu Hoon Lee, Hee-Sang Kim, Ahmed El-Sohemy, Marilyn C Cornelis, Wan-Sik Uhm and Sang-Cheol Bae
    The Journal of Rheumatology July 1 2006, 33 (7) 1231-1234;
  • You have access
    SLC22A4, RUNX1, and SUMO4 polymorphisms are not associated with rheumatoid arthritis: a case-control study in a Spanish population.
    Gisela Orozco, Elena Sánchez, Miguel A González-Gay, Miguel A López-Nevot, Belén Torres, Dora Pascual-Salcedo, Alejandro Balsa, Jose L Pablos, Antonio García, Maria Francisca González-Escribano and Javier Martín
    The Journal of Rheumatology July 1 2006, 33 (7) 1235-1239;
  • You have access
    The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis.
    Anthony S Russell, Al Devani and Walter P Maksymowych
    The Journal of Rheumatology July 1 2006, 33 (7) 1240-1242;
  • You have access
    Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?
    Martin Soubrier, Djamila Zerkak, Laure Gossec, Xavier Ayral, Christian Roux and Maxime Dougados
    The Journal of Rheumatology July 1 2006, 33 (7) 1243-1246;
  • You have access
    Factors associated with permanent work disability in Mexican patients with rheumatoid arthritis. A case-control study.
    Jaime Morales-Romero, Laura Gonzalez-Lopez, Alfredo Celis, Brenda E Rodriguez-Arreola, Carlos E Cabrera-Pivaral and Jorge I Gamez-Nava
    The Journal of Rheumatology July 1 2006, 33 (7) 1247-1249;
  • You have access
    Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years.
    Arvind Rajasekaran, David Shovlin, Vadivelu Saravanan, Philip Lord and Clive Kelly
    The Journal of Rheumatology July 1 2006, 33 (7) 1250-1253;
  • You have access
    The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population.
    Gillian Roberts and Hilary A Capell
    The Journal of Rheumatology July 1 2006, 33 (7) 1254-1257;
  • You have access
    Most rheumatologists are conservative in active rheumatoid arthritis despite methotrexate therapy: results of the PRISME survey.
    Alain Saraux, Valérie Devauchelle-Pensec, Luc Engerran and René Marc Flipo
    The Journal of Rheumatology July 1 2006, 33 (7) 1258-1265;
  • You have access
    Cost-effectiveness analysis of MTHFR polymorphism screening by polymerase chain reaction in Korean patients with rheumatoid arthritis receiving methotrexate.
    Seong-Kyu Kim, Jae-Bum Jun, Ahmed El-Sohemy and Sang-Cheol Bae
    The Journal of Rheumatology July 1 2006, 33 (7) 1266-1274;
  • You have access
    Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis.
    Elizabeth Benito-Garcia, Jenny E Heller, Lori B Chibnik, Nancy E Maher, Heather M Matthews, Jessica A Bilics, Michael E Weinblatt and Nancy A Shadick
    The Journal of Rheumatology July 1 2006, 33 (7) 1275-1281;
  • You have access
    Dimensions of fatigue in systemic lupus erythematosus: relationship to disease status and behavioral and psychosocial factors.
    Deborah Da Costa, Maria Dritsa, Sasha Bernatsky, Christian Pineau, Henri A Ménard, Kaberi Dasgupta, Anahita Keschani, Natalie Rippen and Ann E Clarke
    The Journal of Rheumatology July 1 2006, 33 (7) 1282-1288;
  • You have access
    Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome.
    Sule Yavuz, Ebru Toker, Muge Bicakcigil, Gonca Mumcu and Sezen Cakir
    The Journal of Rheumatology July 1 2006, 33 (7) 1289-1292;
  • You have access
    Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
    Javier Narváez, Berta Bernad, Cesar Díaz Torné, Jaime Vilaseca Momplet, Jordi Zaragoza Montpel, Joan M Nolla and José Valverde-García
    The Journal of Rheumatology July 1 2006, 33 (7) 1293-1298;
  • You have access
    Outcome and prognostic factors during the course of primary small-vessel vasculitides.
    Laura Pavone, Chiara Grasselli, Elisabetta Chierici, Umberto Maggiore, Gianni Garini, Nicoletta Ronda, Paolo Manganelli, Alberto Pesci, Walter Troise Rioda, Bruno Tumiati, Giovanni Pavesi, Augusto Vaglio, Carlo Buzio and Secondary and Primar Vasculitides (Se.Pri.Va) Study Group
    The Journal of Rheumatology July 1 2006, 33 (7) 1299-1306;
  • You have access
    Management of infusion reactions to infliximab in patients with rheumatoid arthritis or spondyloarthritis: experience from an immunotherapy unit of rheumatology.
    Thierry Lequerré, Olivier Vittecoq, Nathalie Klemmer, Vincent Goëb, Sophie Pouplin, Jean-Francois Menard, Alain Daragon, Othmane Mejjad and Xavier Le Loët
    The Journal of Rheumatology July 1 2006, 33 (7) 1307-1314;
  • You have access
    Nail and distal interphalangeal joint in psoriatic arthritis.
    Raffaele Scarpa, Ernesto Soscia, Rosario Peluso, Mariangela Atteno, Francesco Manguso, Antonio Del Puente, Angelo Spanò, Cesare Sirignano, Alfonso Oriente, Matteo Nicola Dario Di Minno, Salvatore Iervolino and Marco Salvatore
    The Journal of Rheumatology July 1 2006, 33 (7) 1315-1319;
  • You have access
    Prostaglandin production by human osteoclasts in culture.
    Josette A Hackett, Hugues Allard-Chamard, Patrice Sarrazin, Maria de Fatima Lucena, Maxime A Gallant, Isabelle Fortier, Moni Nader, Jean-Luc Parent, Ghassan Bkaily and Artur J de Brum-Fernandes
    The Journal of Rheumatology July 1 2006, 33 (7) 1320-1328;
  • You have access
    Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate.
    Pooi-See Chan, John P Caron and Michael W Orth
    The Journal of Rheumatology July 1 2006, 33 (7) 1329-1340;
  • You have access
    Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study.
    David J Hunter, Michael York, Christine E Chaisson, Ryan Woods, Jingbo Niu and Yuqing Zhang
    The Journal of Rheumatology July 1 2006, 33 (7) 1341-1345;
  • You have access
    The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
    Hairong Nan, Qing Qiao, Yanhu Dong, Weiguo Gao, Bin Tang, Rongli Qian and Jaakko Tuomilehto
    The Journal of Rheumatology July 1 2006, 33 (7) 1346-1350;
  • You have access
    Systematic review of the efficacy and safety of shock wave therapy for lateral elbow pain.
    Rachelle Buchbinder, Sally E Green, Joanne M Youd, Willem J J Assendelft, Lesley Barnsley and Nynke Smidt
    The Journal of Rheumatology July 1 2006, 33 (7) 1351-1363;
  • You have access
    Chemotherapy-related arthropathy.
    Mi-Jeong Kim, Young-Min Ye, Hae-Sim Park and Chang-Hee Suh
    The Journal of Rheumatology July 1 2006, 33 (7) 1364-1368;
  • You have access
    Functioning and preferences for improvement of health among patients with juvenile idiopathic arthritis in early adulthood using the WHO ICF model.
    Marja Arkela-Kautiainen, Jarkko Haapasaari, Hannu Kautiainen, Leena Leppänen, Ilpo Vilkkumaa, Esko Mälkiä and Marjatta Leirisalo-Repo
    The Journal of Rheumatology July 1 2006, 33 (7) 1369-1376;
  • You have access
    Epidemiology of juvenile idiopathic arthritis in Alsace, France.
    Stéphanie Danner, Christelle Sordet, Joelle Terzic, Lionel Donato, Michel Velten, Michel Fischbach and Jean Sibilia
    The Journal of Rheumatology July 1 2006, 33 (7) 1377-1381;
  • You have access
    Radiographic and clinical outcome in early juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3-year prospective study.
    Anne M Selvaag, Berit FlatØ, Knut Dale, Gunhild Lien, Odd Vinje, Anna Smerdel-Ramoya and Øystein FØrre
    The Journal of Rheumatology July 1 2006, 33 (7) 1382-1391;
  • You have access
    Enzyme elevation in patients with juvenile dermatomyositis and steroid myopathy.
    Maryam Y Naim and Ann M Reed
    The Journal of Rheumatology July 1 2006, 33 (7) 1392-1394;
  • You have access
    Epitope mapping of anti-alpha-fodrin autoantibody in juvenile Sjögren's syndrome: difference in major epitopes between primary and secondary cases.
    Reza Shiari, Ichiro Kobayashi, Nariaki Toita, Norikazu Hatano, Nobuaki Kawamura, Motohiko Okano, Yoshio Hayashi, Kunihiko Kobayashi and Tadashi Ariga
    The Journal of Rheumatology July 1 2006, 33 (7) 1395-1400;
  • You have access
    Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group.
    Leslie J Crofford, Matthew D Breyer, C Vibeke Strand, Frank Rushitzka, Kay Brune, Michael E Farkouh and Lee S Simon
    The Journal of Rheumatology July 1 2006, 33 (7) 1403-1408;
  • You have access
    Haverhill fever with spine involvement.
    Hani Abdulaziz, Claire Touchie, Baldwin Toye and Jacob Karsh
    The Journal of Rheumatology July 1 2006, 33 (7) 1409-1410;
  • You have access
    Anti-tumor necrosis factor-alpha-induced psoriasis.
    Ismail Sari, Servet Akar, Merih Birlik, Banu Sis, Fatos Onen and Nurullah Akkoc
    The Journal of Rheumatology July 1 2006, 33 (7) 1411-1414;
  • You have access
    Clinical images: Bazin's disease (erythema induratum).
    Manal Al-Mashaleh, Don Packham and Nicholas Manolios
    The Journal of Rheumatology July 1 2006, 33 (7) 1415;
  • You have access
    Spontaneous osteonecrosis of the knee.
    John Y Kim and David R Finger
    The Journal of Rheumatology July 1 2006, 33 (7) 1416;
  • You have access
    Systematic review of treatments for psoriatic arthritis: an evidence based approach and basis for treatment guidelines.
    Arthur F Kavanaugh, Christopher T Ritchlin and GRAPPA Treatment Guideline Committee
    The Journal of Rheumatology July 1 2006, 33 (7) 1417-1421;
  • You have access
    Therapies for peripheral joint disease in psoriatic arthritis. A systematic review.
    Enrique R Soriano and Neil J McHugh
    The Journal of Rheumatology July 1 2006, 33 (7) 1422-1430;
  • You have access
    Therapies for axial disease in psoriatic arthritis. A systematic review.
    Peter Nash
    The Journal of Rheumatology July 1 2006, 33 (7) 1431-1434;
  • You have access
    Therapies for psoriatic enthesopathy. A systematic review.
    Christopher T Ritchlin
    The Journal of Rheumatology July 1 2006, 33 (7) 1435-1438;
  • You have access
    Therapies for dactylitis in psoriatic arthritis. A systematic review.
    Philip S Helliwell
    The Journal of Rheumatology July 1 2006, 33 (7) 1439-1441;
  • You have access
    Conventional systemic agents for psoriasis. A systematic review.
    Bruce E Strober, Kimberly Siu and Kavi Menon
    The Journal of Rheumatology July 1 2006, 33 (7) 1442-1446;
  • You have access
    Biologic therapies for psoriasis. A systematic review.
    Wolf-Henning Boehncke, Jörg Prinz and Alice B Gottlieb
    The Journal of Rheumatology July 1 2006, 33 (7) 1447-1451;
  • You have access
    Therapies for psoriatic nail disease. A systematic review.
    Sarah Cassell and Arthur F Kavanaugh
    The Journal of Rheumatology July 1 2006, 33 (7) 1452-1456;
  • You have access
    Demyelinating disease in a patient with psoriatic arthritis and family history of multiple sclerosis treated with infliximab.
    Teresa Ruiz-Jimeno, Alejandra Carvajal, Cristina Mata and Elena Aurrecoechea
    The Journal of Rheumatology July 1 2006, 33 (7) 1457-1458;
  • You have access
    Giant cell arteritis--the methotrexate debate revisited.
    Doron Rimar, Michael Rozenbaum, Devy Zisman, Nina Boulman, Gleb Slobodin, Lihi Eder, Joy Feld and Itzhak Rosner
    The Journal of Rheumatology July 1 2006, 33 (7) 1458-1459;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 33, Issue 7
1 Jul 2006
  • Table of Contents
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Extravascular Necrotizing Granuloma: A Diagnostic Clue for Eosinophilic Granulomatosis With Polyangiitis
  • Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series
  • Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines
  • Melorheostosis or “Dripping Candle Wax” Bone Disease
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire